
Merck
Europe, Hessen, Germany, Darmstadt
Description
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
Investor Profile
Merck has backed more than 14 startups, with 1 new investments in the last 12 months alone. The firm has led 8 rounds, about 57% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States, Germany, China.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Led 1 rounds in the past year.
Stage Focus
- Grant (21%)
- Series A (14%)
- Seed (14%)
- Series Unknown (14%)
- Post Ipo Equity (14%)
- Series B (7%)
- Series C (7%)
- Series H (7%)
Country Focus
- United States (71%)
- Germany (7%)
- China (7%)
- United Kingdom (7%)
- The Netherlands (7%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Life Science
- Therapeutics
- Biopharma
- Oncology
- Artificial Intelligence (Ai)
- Big Data
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.